Pfizer Options Spot-On: On December 3rd, 127.27K Contracts Were Traded, With 3.33 Million Open Interest
Fresh Closing Highs from S&P 500 and Nasdaq | Wall Street Today
Pfizer's New Chief Scientific Officer Charts R&D Vision For High And Low-Risk Investments
Express News | 'ADA Advises Against Using Compounded GLP-1 RA Medications' - Medscape
Valneva's Chikungunya Shot Shows Strong, Long-Lasting Antibody Persistence At Three Years, Comparable In Older And Younger Adults
Unusual Options Activity: WMT, ULTA and Others Attract Market Bets, WMT V/OI Ratio Reaches 440.4
